Details for New Drug Application (NDA): 202853
✉ Email this page to a colleague
The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 202853
Tradename: | OLOPATADINE HYDROCHLORIDE |
Applicant: | Padagis Israel |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 202853
Mechanism of Action | Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 202853
Suppliers and Packaging for NDA: 202853
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 202853 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-104 | 45802-104-01 | 1 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE |
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 202853 | ANDA | Bryant Ranch Prepack | 63629-8434 | 63629-8434-1 | 1 BOTTLE in 1 CARTON (63629-8434-1) / 240 SPRAY in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;NASAL | Strength | 0.665MG/SPRAY | ||||
Approval Date: | Jan 31, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription